XML 78 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock and Stock Plans (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Common Stock Shares
Table 12.1 presents our reserved, issued and authorized shares of common stock at December 31, 2023.

Table 12.1: Common Stock Shares
Number of shares 
Shares reserved (1)259,837,463 
Shares issued5,481,811,474 
Shares not reserved or issued3,258,351,063 
Total shares authorized9,000,000,000 
(1)Shares reserved for employee stock plans (employee restricted share rights, performance share awards, 401(k), and deferred compensation plans), convertible securities, dividend reinvestment and common stock purchase plans, and director plans.
Stock Compensation Expense
Table 12.2 summarizes the major components of stock compensation expense and the related recognized tax benefit.
Table 12.2: Stock Compensation Expense
Year ended December 31,
(in millions)202320222021
RSRs $1,069 947 931 
Performance shares (1)53 31 74 
Total stock compensation expense $1,122 978 1,005 
Related recognized tax benefit$277 242 248 
(1)Compensation expense fluctuates with the estimated outcome of satisfying performance conditions and, for certain awards, changes in our stock price.
Restricted Share Rights A summary of the status of our RSRs at December 31, 2023, and changes during 2023 is presented in Table 12.3.
Table 12.3: Restricted Share Rights
Number Weighted- 
 average 
 grant-date 
 fair value 
Nonvested at January 1, 2023
53,237,143 $42.44 
Granted 29,938,962 44.15 
Vested(21,562,727)42.92 
Canceled or forfeited(2,066,131)43.91 
Nonvested at December 31, 2023
59,547,247 43.07 
Performance Share Awards
A summary of the status of our PSAs at December 31, 2023, and changes during 2023 is in Table 12.4, based on the performance adjustments recognized as of December 2023.

Table 12.4: Performance Share Awards
Number 
Weighted- 
 average 
 grant-date 
 fair value (1)
Nonvested at January 1, 2023
4,508,337 $36.81 
Granted1,193,556 44.33 
Vested(766,527)42.67 
Canceled or forfeited(647,543)45.73 
Nonvested at December 31, 2023
4,287,823 36.51 
(1)Reflects approval date fair value for grants subject to variable accounting.
Wells Fargo ESOP Fund presents the information related to the Wells Fargo ESOP Fund and the dividends paid to the 401(k) Plan.
Table 12.5: Wells Fargo ESOP Fund
December 31,
(in millions, except shares)202320222021
Allocated shares outstanding (common)144,140,446 152,438,152 149,638,081 
Unreleased shares outstanding (common) 10,329,650 — 
Fair value of unreleased shares outstanding (common)$ 427 — 
Unreleased shares outstanding (preferred) — 609,434 
Conversion value of unreleased ESOP preferred shares$ — 609 
Fair value of unreleased ESOP preferred shares based on redemption — 700 
Year ended December 31,
Dividends paid on (in millions):202320222021
Allocated shares (common)$161 134 74 
Unreleased shares (common) (1)13 — 
Unreleased shares (preferred) 36 66 
(1)Included dividends paid in fourth quarter 2023 after shares were released and prior to allocation to participants.